BE785518A - Methode d'extraction des substances proteiniques et lipidiques du serumet du plasma sanguins - Google Patents

Methode d'extraction des substances proteiniques et lipidiques du serumet du plasma sanguins

Info

Publication number
BE785518A
BE785518A BE785518A BE785518A BE785518A BE 785518 A BE785518 A BE 785518A BE 785518 A BE785518 A BE 785518A BE 785518 A BE785518 A BE 785518A BE 785518 A BE785518 A BE 785518A
Authority
BE
Belgium
Prior art keywords
serumet
blood plasma
extracting protein
lipidic substances
lipidic
Prior art date
Application number
BE785518A
Other languages
English (en)
Inventor
L F Fekete
F Peetoom
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of BE785518A publication Critical patent/BE785518A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06—Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08—Saturated oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE785518A 1971-06-29 1972-06-28 Methode d'extraction des substances proteiniques et lipidiques du serumet du plasma sanguins BE785518A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15811171A 1971-06-29 1971-06-29

Publications (1)

Publication Number Publication Date
BE785518A true BE785518A (fr) 1972-12-28

Family

ID=22566730

Family Applications (1)

Application Number Title Priority Date Filing Date
BE785518A BE785518A (fr) 1971-06-29 1972-06-28 Methode d'extraction des substances proteiniques et lipidiques du serumet du plasma sanguins

Country Status (7)

Country Link
US (1) US3770631A (fr)
BE (1) BE785518A (fr)
CA (1) CA1009573A (fr)
DE (1) DE2231676A1 (fr)
FR (1) FR2143894B1 (fr)
GB (1) GB1366246A (fr)
NL (1) NL7209015A (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880989A (en) * 1973-01-30 1975-04-29 Baxter Laboratories Inc Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4000121A (en) * 1973-01-30 1976-12-28 Baxter Travenol Laboratories, Inc. Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
US3955925A (en) * 1973-11-12 1976-05-11 Proksch Gary J Preparation of optically clear serum
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
US3959128A (en) * 1974-12-27 1976-05-25 Preventive Systems, Inc Process for removing endotoxin from biological fluids
US3944391A (en) * 1974-12-27 1976-03-16 Preventive Systems, Inc. In vitro process for detecting endotoxin in a biological fluid
US4059512A (en) * 1974-12-27 1977-11-22 Preventive Systems, Inc. Process for removing endotoxin from biological fluids
US3958939A (en) * 1975-01-08 1976-05-25 Coulter Electronics, Inc. Method for clarification of lipemic serum
US4086218A (en) * 1975-04-11 1978-04-25 Edward Shanbrom, Inc. Method of preserving blood plasma II
US4189425A (en) * 1975-04-11 1980-02-19 Edward Shanbrom, Inc. Method of preserving blood plasma I
US4103685A (en) * 1976-01-05 1978-08-01 Lupien Paul J Method and apparatus for extravascular treatment of blood
CA1101332A (fr) * 1976-01-30 1981-05-19 Edward Shanbrom Procedes simplifies pour la preparation de concentres de facteur viii de tres grande purete
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4137223A (en) * 1977-05-16 1979-01-30 Edward Shanbrom, Inc. Method of preserving blood plasma II
DE2724757C2 (de) * 1977-06-01 1979-08-23 Boehringer Mannheim Gmbh, 6800 Mannheim Mittel zur Beseitigung von Trübungen in Serum und Verfahren zu seiner Herstellung
FR2441172A1 (fr) * 1978-11-10 1980-06-06 Ryan Wayne Etalon de reference pour la numeration des plaquettes sanguines et son procede de preparation
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii
US4330622A (en) * 1979-09-12 1982-05-18 Becton Dickinson & Co. Elimination of non-microbial turbidity in culture media
US4980403A (en) * 1986-01-06 1990-12-25 The University Of Melbourne Collagen products
US4919811A (en) * 1988-01-14 1990-04-24 The Standard Oil Company Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof
US5006287A (en) * 1988-01-14 1991-04-09 The Standard Oil Company Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
DK2130554T3 (da) 1999-02-22 2012-12-03 Univ Connecticut Albuminfrie faktor VIII-præparater
DE10045434B4 (de) * 2000-09-14 2005-07-14 Fresenius Hemocare Gmbh Adsorbens mit unterschiedlich modifizierten Oberflächenbereichen, Verfahren zu dessen Herstellung und Verwendung davon
AU2009313325B2 (en) 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
PL3102704T3 (pl) * 2014-02-07 2021-01-11 University Of Iowa Research Foundation Sondy oparte na oligonukleotydach i sposoby wykrywania drobnoustrojów

Also Published As

Publication number Publication date
FR2143894B1 (fr) 1975-10-31
GB1366246A (en) 1974-09-11
FR2143894A1 (fr) 1973-02-09
DE2231676A1 (de) 1973-01-18
CA1009573A (en) 1977-05-03
US3770631A (en) 1973-11-06
NL7209015A (fr) 1973-01-03

Similar Documents

Publication Publication Date Title
BE785518A (fr) Methode d'extraction des substances proteiniques et lipidiques du serumet du plasma sanguins
AT324549B (de) Verfahren zur isolierung von antithrombin aus blutplasma oder plasmaprotein
CA1010710A (en) Protein and method of extracting same from soybeans
OA03719A (fr) Substances comestibles contenant des proteines et procédé de leur préparation.
IT1058477B (it) Procedimento per estrarre proteine da soluzioni proteiniche acquose
CH547079A (de) Filtervorrichtung zur herstellung von aroma-auszuegen.
BE781532A (fr) Separation des lymphocytes du sang
IT1125225B (it) Procedimento e dispositivo per la separazione di macromolecole da una sostanza fluida che le contiene in particolare per ottenere proteine dal latte
DK132989C (da) Fremgangsmade til adskillelse af blod i fraktioner og centrifuge til udovelse af fremgangsmaden
CA965560A (en) Process and device for extracting blood from slaughtered animals
SE7504684L (sv) Forfarande for utvinning av kott och anordning herfor.
BE757597A (fr) Methode et machine de traitement des graines de soja
NL7605539A (nl) Werkwijze voor de bereiding van preparaten met analgetische en bloeddrukverlagende werking.
BE773121A (fr) Preparations pharmaceutiques destinees au traitement des hyperlipidemies et leur procede d'obtention
CH530765A (de) Vorrichtung zur Behandlung von verarbeitetem Tabak
BE825857A (fr) Procede d'extraction et de traitement de glycoproteines, de mucopolysaccharides et de substances qui les accompagnent
DD127755A5 (de) Methode zur behandlung von fluessigkeiten,die blutsubstanzen enthalten
BE825245A (fr) Nouvelles 2-amino-6-dialkylaminodihydropyridines leur procede de preparation et medicament les contenant
IT986018B (it) Metodo per il trattamento di pro teina da siero e prodotto ottenuto
IL34196A (en) Method of separating leukocytes from blood
FR2292474A1 (fr) Nouveaux diaryloxy-imidazolyl-o,n-acetals, leur procede de preparation et medicament les contenant
BE784970A (fr) Nouveaux peptides et procedes pour leur preparation
FR1499622A (fr) Procédé et appareil pour la séparation de tissus vasculaires des tissus mous dans les légumes verts
OA04776A (fr) Procédé d'extraction du solvant contenu dans des protéines.
BE848830A (fr) Nouveau procede d'extraction de peaux embryonnaires de veaux, substances proteiniques obtenues, et compositions cosmetique et pharmaceutique les contenant